Pulmonary arterial hypertension trials recruiting in Kansas

All Pulmonary arterial hypertension trials nationally

Cities in Kansas

Recruiting trials in Kansas

• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
  NCT07365332 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Kansas: Kansas City
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Kansas: Kansas City
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Kansas: Kansas City
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Kansas: Kansas City
• Pulmonary Hypertension Biorepository and Registry
  NCT04808596 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Kansas City